Di Jin, Kai Kang, Bing-Zhu Yan, Jian-Nan Zhang, Jun-Bo Zheng, Zhi-Hui Wang, Di Wu, Yu-Jia Tang, Xin-Tong Wang, Qi-Qi Lai, Yang Cao, Hong-Liang Wang, Yang Gao
BACKGROUND: Acute liver failure (ALF), previously known as fulminant hepatic failure, has become a common, rapidly progressive, and life-threatening catastrophic hepatic disease in intensive care unit (ICU) due to the continuous increase in drug abuse, viral infection, metabolic insult, and auto-immune cause. At present, plasma exchange (PE) is the main effective alternative treatment for ALF in ICU clinical practice, and high-volume plasma exchange (HVP) has been listed as a grade I recommendation for ALF management in the American Society for Apheresis (ASFA) guidelines...
2023: Canadian Journal of Gastroenterology & Hepatology